Invivyd

Last updated: July 24, 2024

CEO - Dave Hering
CEO - Dave Hering
USA | Funding: $466M (+)

Website: https://invivyd.com/

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.